Early in CKD, FGF23 increases to maintain normal blood phosphate levels, while suppressing 1,25-vitamin D. However, this compensatory mechanism ultimately fails, leading to hyperphosphatemia and hyperparathyroidism (90, 92). Here, FGF23 is linked to chronic kidney disease.